REDUCEDT+7
Arbutus Biopharma Corp · NASDAQ
−24,655 sh · $123.3K
Filed 7 Oct 2026SEC Form 4view source
- ACQUIREDT+30
Arbutus Biopharma Corp · NASDAQ
+10,456 sh · $45.9K
Filed 23 Sept 2026SEC Form 4view source - REDUCEDT+30
Arbutus Biopharma Corp · NASDAQ
−82,527 sh · $418.4K
Filed 23 Sept 2026SEC Form 4view source - ACQUIREDT+30
Arbutus Biopharma Corp · NASDAQ
+116,408 sh · $372.5K
Filed 23 Sept 2026SEC Form 4view source